Asia-Pacific Pneumococcal Disease Control in the Pneumococcal Conjugate Vaccine Era [ 11/1/2020 - 10/31/2025 ]

Research Grant

Brief description Pneumonia is one of the commonest causes of childhood death worldwide. PCV is a vaccine that prevents pneumonia but it is costly; and causes an increase in disease from strains which are not in the vaccine. Our CRE will address 2 outstanding issues: when to switch from a 3 to 2 dose PCV schedule to make it more affordable; and create new understanding of the non-vaccine strains’ impact on disease in low- and middle-income countries in the Asia-Pacific region.

Funding Amount $2,500,000.00

Funding Scheme Centres of Research Excellence

Chief Investigator Prof Fiona Russell

Notes Centre of Research Excellence - Public Health